
|Articles|August 2, 2001
- Pharmaceutical Technology-08-02-2001
- Volume 25
- Issue 8
Changes and Challenges for CDER
Author(s)Jill Wechsler
The Center for Drug Evaluation and Research is adopting new approaches to how it oversees the development and approval of new drugs and how it ensures the safe use of prescription drugs by the public.
Advertisement
Articles in this issue
over 24 years ago
Report on the Industry Blend Uniformity Practices Surveyover 24 years ago
Interphex Presents a Wide Array of Packaging InnovationsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Year of the Tariff: Pharmaceutical Supply Chain Reimagined in 2025
2
Autonomy Isn’t Binary: How Agentic AI Fits into the Pharma Landscape
3
PharmTech’s Top 10 Articles of 2025
4
Global Collaboration and Technological Acceleration to Evolve Drug Innovation
5




